A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The study contains three periods: screening, inpatient hospitalization and follow-up. And should be leaded as a randomized placebo-controlled study with in chain order enrolled volunteers and dose escalating.
Epistemonikos ID: 8b0c34482685b3d68afa229388acc29b70123440
First added on: May 20, 2024